Amy Elazzouzi
Fortune : 901 808 $ au 30/09/2026
Fortune : 901 808 $ au 30/09/2026
Amy Elazzouzi is currently Principal Financial Officer, Secretary & Treasurer at Aura Biosciences, Inc. since 2026.
Former positions include Director-Finance & Operations at Kew, Inc. and Controller at AVEO Pharmaceuticals, Inc. Education includes an MBA from Northeastern University and an undergraduate degree from Regis College.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AURA BIOSCIENCES INC 0,14% | 01/09/2026 | 143 600 ( 0,14% ) | 901 808 $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AURA BIOSCIENCES, INC. | Directeur Financier/CFO | 02/09/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | - |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Directeur Financier/CFO | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Aura Biosciences, Inc.
Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Northeastern University
Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regis College
Regis College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Kew, Inc.
Kew, Inc. Medical/Nursing ServicesHealth Services Provides oncology services | Health Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national